Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis

Anna Paola Batocchi, Francesco Patti, Mp Amato, S Bastianello, L Caniatti, E Di Monte, P Ferrazza, B Goretti, P Gallo, Vb Morra, S Lo Fermo, O Picconi, Mr Tola, M Trojano, Cogimus Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences